BioMarkIQ

Pune, India Founded: 2023 • Age: 3 yrs
Provides diagnostic solutions and research aids in biotechnology field.

About BioMarkIQ

BioMarkIQ is a Technology company based in Pune (India) founded in 2023. It provides diagnostic solutions and research aids in biotechnology field. It operates on a B2B and SaaS model in Technology and Healthcare sectors. BioMarkIQ has raised $157.33 thousand across 4 funding rounds from investors including Scitech Park. Its Indian entity Biomarkiq Scientific Technologies Private Limited reported revenue of β‚Ή1.1 Lakh. BioMarkIQ offers products and services including VarSee and ResearchRadar. Its focus areas include Education, Research Tech, Literature Management and AI Recommendations.

Company details

BioMark IQ is a biotechnology firm focused on advancing diagnostic solutions and research tools. It offers products like VarSee for early lung cancer detection through biomarkers and AI technology, emphasizing precision in health analysis. Additionally, ResearchRadar assists researchers by providing quick access to relevant articles and recommendations. The company prioritizes innovation in disease detection and literature management, though specific locations and clients are not detailed.

Key Metrics
  • Annual Revenue
    ₹1.1 Lakh

    FY 2025 · +300% YoY

  • Net Loss
    -₹27,500

    FY 2025 · -25% margin

  • EBITDA
    -₹26,500

    FY 2025 · -25% margin

  • Total Equity Funding
    $157.33K (USD)

    in 4 rounds

  • Latest Funding Round
    $10.56K (USD), Seed

    Mar 2026

  • Investors

Products & Services of BioMarkIQ

BioMarkIQ offers a comprehensive portfolio of products and services, including VarSee and ResearchRadar.

VarSee
Diagnostic Tool

AI-based system for early lung cancer detection using biomarkers.

ResearchRadar
Research Platform

Tool for accessing and recommending relevant research articles quickly.

Funding Insights of BioMarkIQ

BioMarkIQ has successfully raised a total of $157.33K across 4 strategic funding rounds. The most recent funding activity was a Seed round of $10.56 thousand completed in March 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $157,325
  • Total Rounds 4
  • Last Round Seed β€” $10,557
  • First Round $68,106

    (Sep 2025)

  • Investors Count 1

All 4 funding rounds of BioMarkIQ with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2026$10,557Seed––
–
Mar 2026$10,557Seed––
–
Sep 2025$68,106Seed–Scitech Park
–
Sep 2025$68,106Seed–Scitech Park
–
Valuation history

1 investors in total: 1 institutional.

Investors in BioMarkIQ

BioMarkIQ has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Scitech Park.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
scitechpark.org.in
Premium access

Investor details for BioMarkIQ

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Biomarkiq Scientific Technologies Private Limited (BioMarkIQ)

Biomarkiq Scientific Technologies Private Limited is the primary company behind BioMarkIQ. The board of Biomarkiq Scientific Technologies Private Limited currently have 2 directors; the longest-serving is Snahlata Singh, appointed in 2023.

DirectorDesignationAppointedTenureEntity
Snahlata Singh
DIN 09112188
Director30 Mar 20233 yrs 6 moBiomarkiq Scientific Technologies Private Limited
Manasi Nachiket Khasnis
DIN 10094863
Director30 Mar 20233 yrs 6 moBiomarkiq Scientific Technologies Private Limited

Financials of BioMarkIQ

Figures of Biomarkiq Scientific Technologies Private Limited, the primary company behind BioMarkIQ, for FY 2025. Revenue was ₹1.1 Lakh (+300% year on year). Net loss was -₹27,500 (-25% margin). EBITDA was -₹26,500 (-25% margin).

  • ₹1.1 LakhRevenue · FY 2025 · +300% YoY
  • -₹27,500Net loss · -25% margin
  • -₹26,500EBITDA · -25% margin
  • ₹5.4 LakhPaid-up capital

Balance sheet, profit and loss, cash flow and ratios of Biomarkiq Scientific Technologies Private Limited are on its company page.

Premium access

Detailed financial statements for BioMarkIQ

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of BioMarkIQ

3 dated milestones of BioMarkIQ across 3 years, from founding to its latest funding, stage changes and deals.

  1. Founded BioMarkIQ is founded.
  2. Funding First funding round of $68K.
  3. Funding Latest funding round, Seed, of $11K.

Top companies in AI in Human Resources

3 companies that operate in the same segment as BioMarkIQ (AI in Human Resources) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
An AI-powered platform for assessments and hiring solutions.
2017Bengaluru, Karnataka, IndiaUSD 918.13 K30
Provides AI-based HR software for payroll, attendance, and employee engagement.
2013Mumbai, Maharashtra, India
AI-powered platform for employee engagement measurement and coaching.
2018Mumbai, Maharashtra, India30
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about BioMarkIQ

BioMarkIQ was founded in 2023 and raised its 1st funding round 2 years after it was founded.

BioMarkIQ is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.

BioMarkIQ is a funded company, having raised a total of $157.33K across 4 funding rounds to date. The company's 1st funding round was a Seed of $68.11K, raised on Sep 2025.

The primary company behind BioMarkIQ, Biomarkiq Scientific Technologies Private Limited, reported revenue of β‚Ή1.1 Lakh for FY 2025, up 300% year on year.

BioMark IQ is a biotechnology firm focused on advancing diagnostic solutions and research tools. It offers products like VarSee for early lung cancer detection through biomarkers and AI technology, emphasizing precision in health analysis. Additionally, ResearchRadar assists researchers by providing quick access to relevant articles and recommendations. The company prioritizes innovation in disease detection and literature management, though specific locations and clients are not detailed.

BioMarkIQ offers VarSee and ResearchRadar.

BioMarkIQ has 1 investor. Key investors include Scitech Park.

BioMarkIQ operates through Biomarkiq Scientific Technologies Private Limited.

The legal entities of BioMarkIQ currently have 2 directors, including Snahlata Singh, Manasi Nachiket Khasnis.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available